DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

31.96 1.59 (5.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACAD $31.96 5.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $30.41
Previous Close $30.37
Daily Range $30.41 - $32.12
52-Week Range $15.64 - $46.48
Market Cap $3.2B
P/E Ratio -31.97
Dividend (Yield) $0.00 (0.0%)
Volume 2,173,143
Average Daily Volume 2,723,934
Current FY EPS -$0.89

Sector

Healthcare

Industry

Drug Makers

ACADIA Pharmaceuticals, Inc. (ACAD) Description

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Website: http://www.acadia-pharm.com/

News & Commentary

This Exciting Biotech Isn't Built to Last

Acadia Pharmaceuticals' Parkinson's disease drug was guaranteed a speedy review and the attention of top FDA officials. So why did this company's stock recently tank so rapidly? There's a cautionary tale here for all biotech investors.

First Week of May 15th Options Trading For Acadia Pharmaceuticals (ACAD)

ACADIA Pharmaceuticals At $30: The Upside Doesn't Justify The Risk

Three Iconic Stocks to Short

The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releas

The Zacks Analyst Blog Highlights: Amgen, Regeneron, Nektar, ACADIA and Pharmacyclics - Press Releases

Bluebird Bio Is Overheated - Cramer's Lightning Round (3/13/15)

Acadia Has Tough Road Ahead With Nuplazid Success

'Mad Money' Lightning Round: Dave and Buster's Is Too Risky for Me

ACADIA Down on Nuplazid NDA Delay and CEO Resignation - Analyst Blog

ACADIA Pharmaceuticals (ACAD) Crumbles: Stock Falls by 22.2% - Tale of the Tape

See More ACAD News...

ACAD's Top Competitors

ACAD $31.96 (5.24%)
Current stock: ACAD
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB